Skip to content

Increased risk of oral contraceptive failure with nelfinavir

Keeping viral load below 20,000 copies/ml still beneficial, even after HIV rebound

WHO issues guidance on what to do about delisted ARVs

Viral load one month after starting HAART predicts who will be detectable after six months treatment

WHO issues guidance for doctors, governments, patients on what to do about delisted ARVs

Tenofovir/FTC edges ahead of Combivir in head to head study at week 24

DAD study: 26% increased risk of stroke, angioplasty or bypass surgery for each year on HAART

New protease inhibitor, Telzir, now available for prescription in UK

Global Fund launches online tool to aid transparency on drug prices